Literature DB >> 8292114

Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm.

A J Magill1, M Grögl, R A Gasser, W Sun, C N Oster.   

Abstract

BACKGROUND: Visceral leishmaniasis, usually caused by Leishmania donovani, has rarely been reported from eastern Saudi Arabia, so it was not expected to affect the soldiers of Operation Desert Storm.
METHODS: We evaluated eight soldiers with visceral leishmanial infection, examining their serum with an immunofluorescent-antibody assay, examining their marrow or biopsy tissue for amastigotes with an indirect immunofluorescent-monoclonal-antibody assay, and culturing the parasites. Cultured promastigotes were isolated and characterized by isoenzyme analysis.
RESULTS: None of the eight soldiers had classic signs or symptoms of visceral leishmaniasis (kala-azar). Seven soldiers had unexplained fever, chronic fatigue, malaise, cough, intermittent diarrhea, or abdominal pain that began up to seven months after they returned to the United States; one had no symptoms. Five had adenopathy or mild, transient hepatosplenomegaly. None had cutaneous manifestations. Diagnoses were made by bone marrow aspiration (seven patients) or lymph-node biopsy (one patient). Six isolates have been identified as L. tropica, which usually causes only cutaneous disease. Of the six patients treated with sodium stibogluconate, five improved and one remained symptomatic.
CONCLUSIONS: L. tropica can produce visceral infection that can cause unexplained systemic illness in persons returning from areas where this organism is endemic.

Entities:  

Mesh:

Year:  1993        PMID: 8292114     DOI: 10.1056/NEJM199305133281904

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  64 in total

1.  Imported visceral leishmaniasis: diagnostic dilemmas and comparative analysis of three assays.

Authors:  Jamshaid Iqbal; Parsotam R Hira; Grover Saroj; Reeni Philip; Faiza Al-Ali; Patrick J Madda; Ali Sher
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

Review 2.  Laboratory diagnosis of visceral leishmaniasis.

Authors:  Shyam Sundar; M Rai
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

3.  Novel compounds active against Leishmania major.

Authors:  Stephanie St George; Jeanette V Bishop; Richard G Titus; Claude P Selitrennikoff
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

4.  Use of oral miltefosine for cutaneous leishmaniasis in Canadian soldiers returning from Afghanistan.

Authors:  Yoav Keynan; Oscar E Larios; Marni C Wiseman; Marie Plourde; Marc Ouellette; Ethan Rubinstein
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-11       Impact factor: 2.471

5.  Epidemic infections and their relevance to the Gulf and other Arabian Peninsula countries.

Authors:  Euan M Scrimgeour
Journal:  J Sci Res Med Sci       Date:  2003-08

Review 6.  [Kala azar. Rare import and significant differential diagnosis].

Authors:  H Sudeck
Journal:  Internist (Berl)       Date:  2006-08       Impact factor: 0.743

7.  Characterization of a Leishmania tropica antigen that detects immune responses in Desert Storm viscerotropic leishmaniasis patients.

Authors:  D C Dillon; C H Day; J A Whittle; A J Magill; S G Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells.

Authors:  Susana Mendez; Ryan Traslavina; Meleana Hinchman; Lu Huang; Patricia Green; Michael H Cynamon; John T Welch
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

9.  Identification and differentiation of Leishmania species in clinical samples by PCR amplification of the miniexon sequence and subsequent restriction fragment length polymorphism analysis.

Authors:  Jutta Marfurt; Abed Nasereddin; Igor Niederwieser; Charles L Jaffe; Hans-Peter Beck; Ingrid Felger
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  The biology and control of leishmaniasis vectors.

Authors:  David M Claborn
Journal:  J Glob Infect Dis       Date:  2010-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.